Skip to main content

Fluid-filled bio bag keeps baby lambs alive for weeks, may help preemies survive

An artificial womb has been used to keep premature baby lambs alive for weeks, according to a new study from the Children’s Hospital of Philadelphia and it may some day be used for humans as well. The fluid-filled plastic bio bags mimic the environment inside the uterus.

“Our system could prevent the severe morbidity suffered by extremely premature infants by potentially offering a medical technology that does not currently exist,” Alan W. Flake, a fetal surgeon at CHOP and study lead, said in a statement.

Recommended Videos

In the study, lambs that could not otherwise survive on their own were able to survive up to four weeks in the artificial womb, giving them enough time to sufficiently develop their lungs and other organs. As they would in their mother’s womb, the babies breathed amniotic fluid, pumping blood through an umbilical chord into an external device, exchanging oxygen and carbon dioxide.

Recreating the Womb: New Hope for Premature Babies

Around 30,000 babies are born younger than 26 weeks in the United States every year, a period known as “critically preterm,” causing them to need extensive care to survive. After 28 weeks, the baby passes a threshold that should ensure healthy development. Just about half of babies born before 24 weeks do survive but face a life of medical challenges.

Please enable Javascript to view this content

“These infants have an urgent need for a bridge between the mother’s womb and the outside world,” Flake said. “If we can develop an extra-uterine system to support growth and organ maturation for only a few weeks, we can dramatically improve outcomes for extremely premature babies.”

CHOP’s new bio bag may offer these newborns a safer, more wholesome environment to mature in. However, the device is still only proven to sustain lambs and the researchers said they will be careful not to overextend its ability. Flake and his team have patented the device and are consulting the Food and Drug Administration before conducting preclinical animal trials within the next few years.

A paper detailing the study was published this week in the journal Nature Communications.

Dyllan Furness
Former Digital Trends Contributor
Dyllan Furness is a freelance writer from Florida. He covers strange science and emerging tech for Digital Trends, focusing…
Faraday Future could unveil lowest-priced EV yet at CES 2025
Faraday Future FF 91

Given existing tariffs and what’s in store from the Trump administration, you’d be forgiven for thinking the global race toward lower electric vehicle (EV) prices will not reach U.S. shores in 2025.

After all, Chinese manufacturers, who sell the least expensive EVs globally, have shelved plans to enter the U.S. market after 100% tariffs were imposed on China-made EVs in September.

Read more
What to expect at CES 2025: drone-launching vans, mondo TVs, AI everywhere
CES 2018 Show Floor

With 2024 behind us, all eyes in tech turn to Las Vegas, where tech monoliths and scrappy startups alike are suiting up to give us a glimpse of the future. What tech trends will set the world afire in 2025? While we won’t know all the details until we hit the carpets of the Las Vegas Convention Center, our team of reporters and editors have had an ear to the ground for months. And we have a pretty good idea what’s headed your way.

Here’s a sneak peek at all the gizmos, vehicles, technologies, and spectacles we expect to light up Las Vegas next week.
Computing

Read more
These unique smart glasses skirt hype and solve a real medical problem
Front view of the SolidddVision smartglasses.

Smart glasses are increasingly being pushed as the future of personal computing. But so far, an overwhelming majority have focused on aspects like social media sharing, pulling up AI agents, or media consumption. Soliddd wants to push smart glasses into a challenging niche of medical science.

At CES 2025, the New York City-based company introduced SolidddVision smart glasses. Soliddd claims these are “the first true vision correction for people living with vision loss due to macular degeneration.” Notably, these glasses won’t require any FDA clearance and will enter the market later this year.

Read more